Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer HealthCare AG, Germany.
Bayer HealthCare AG, Germany is the sponsor of the trial.
Age
16–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Chinese origin
diagnosis of Relapsing remitting multiple sclerosis or secondary progressive multiple sclerosis
You may not be if
Any disease other than Multiple Sclerosis (MS) that could better explain the patients signs and symptoms
HIV (human immunodeficiency virus) infections
Hepatitis A
Syphilis
immunodeficiency
rheumatic disease or Sjogren syndrome
heart disease
severe depression
pregnancy or lactation
conditions interfering with Magnetic Resonance Imaging (MRI)
allergy against human proteins, paracetamol, acetaminophen and ibuprofen intolerance
participation in other trial
Clareo Health | Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis
